VitriVax

VitriVax

VitriVax

  • VitriVax just raised $87M (Series C) on Nov 18

An innovative vaccine development and formulation technology company.

Active52Boulder, United States
Rate

About

An innovative vaccine development and formulation technology company. VitriVax is an innovative vaccine development and formulation technology company focused on advancing vaccine candidates, including a Lyme disease vaccine candidate with a novel mechanism of action.

Where VitriVax is heading

Updated Nov 18, 2026, from 9 sources

VitriVax is a vaccine formulation company developing candidates for Lyme disease, rabies, polio, and other infectious diseases using a proprietary platform.vitrivaxbio.com Its recent record shows a step-by-step progression from early grants and a DoD contract toward equity financing aimed at bringing its Lyme disease vaccine into clinical trials.vitrivaxbio.combusinesswire.com

  1. Jul 2021

    Raised a Series A to build out its vaccine formulation platform.vitrivaxbio.com

  2. Jul 2023

    Received a $29M DoD contract to fund vaccine research.vitrivaxbio.com

  3. Dec 2024

    Received a $3.6M grant for polio vaccine development, adding a second disease area to the pipeline.vitrivaxbio.com

  4. Apr 2025

    Received a $5M CEPI grant for rabies vaccine development.vitrivaxbio.com

  5. Oct 2025

    Raised $17.25M in Series B financing and secured a $9.9M manufacturing grant to scale clinical production.vitrivaxbio.com

  6. Nov 2026

    Raised $87M in Series C financing to advance its Lyme disease vaccine candidate into clinical trials.vitrivaxbio.combusinesswire.com

What it points to: Its recent financing record points to entering clinical trials with the Lyme disease vaccine candidate, with the $87M Series C providing the capital to do so.vitrivaxbio.combusinesswire.com

Signals agent

Reach companies that have budget right now

Every week the agent finds companies in your market that just got money or started hiring to spend it, and the person to talk to. You choose who to reach; nothing is sent for you.

  • Just raised a roundFresh budget, the week it lands
  • Hiring sales and marketingGo-to-market roles mean money to spend
  • Hiring fastA jump in open roles across the company
  • In the newsLaunches and announcements worth a message
  • The decision makerWho to contact, with a message you can edit

Is your startup an alternative to VitriVax?

People comparing tools land here. Get listed beside these.

Copy VitriVax's SEO strategy

How often they publish, which searches their posts chase and their newest posts. Then outrank them.

All funding rounds

Key facts

Website
vitrivaxbio.com
Headquarters
Boulder, Colorado, United States
Employees
52
Total funding
$104M (Series C)
Business model
B2B

Funding rounds

Funding rounds raised by VitriVax
DateRoundAmountLead investors
18 Nov 2026Series C$87MF-Prime, NEA, RA Capital, Sanofi Ventures
22 Oct 2025Series B$17MRA Capital

Tech stack

Detected on vitrivaxbio.com, last scanned 18 Nov 2026.

Email provider
Microsoft 365

Benchmarking

See how your site ranks against 16,849 startups

VitriVax sits in the 42nd percentile for Domain Rating. Check where yours lands, free.

Check your Domain Rating

VitriVax has a Domain Rating of 34, the 42nd percentile of 16,849 startups we track.

Scores

Measured, not editorial

34

Measured by AhrefsAhrefs DR

Strength of the site’s backlink profile, on Ahrefs’ 0-100 Domain Rating scale. Licensed third-party data, not our opinion.

Below median

Check yours
37

Measured by StartupHub.aiAgent Readiness

How well an AI agent can read and use this site: structured data, clean markup, and whether key facts are reachable without running JavaScript. We scan the live site.

Below median

Scan yours
56

Measured by Google PageSpeedSite Speed

Google PageSpeed mobile performance for the company’s own site. Measured by Google, not by us.

Below median

PageSpeed
82

Measured by StartupHub.aiData Trust

Whether this company is a safe place to put your data: security posture, privacy signals, and reputation evidence we could verify.

Top 25%

Measured by StartupHub.aiSecurity

What this company’s API or MCP server gives an anonymous stranger: transport, whether anything answers without credentials, CORS, response headers and, when an MCP server replies, which of its tools can be called with no key. Scanned live, on request, because a security verdict months old is worse than none.

Click to scan

Agent Readiness

Can AI agents use your site?

VitriVax scores 37. Check yours free in a few seconds, or let Max Agent rerun it daily.

Run it daily with Max Agent
Median 41Across 23,755 scanned sites

Get notified when VitriVax changes

Used VitriVax? Write a review and get $5 in credits

Your first review on StartupHub.ai adds 1,250 credits to your account. Spend them on:

  • Email finder
  • Market Map Maker
  • Agent Readiness scans
  • Deep intel
  • Tech stack scans

Frequently asked

Is VitriVax growing?

Yes, fast. Our data shows it raised $87M in a Series C in November 2026, more than the $17M it raised in all the years before.

Who owns VitriVax?

VitriVax is privately held, owned by its founders and investors. RA Capital has backed 2 of the 2 rounds on record since October 2025, so it is likely among the largest outside shareholders. Exact stakes are not public.

Are there companies like VitriVax?

Yes. We list 8 companies like VitriVax, including Pfizer, Moderna and ImmunityBio.

Is VitriVax trustworthy and reputable?

StartupHub's Data Trust & Reputation score for VitriVax is 82 out of 100, a trusted rating, based on site security posture, privacy practices, malware and phishing checks, and public reputation signals.

How much funding has VitriVax raised?

VitriVax has raised a total of $104M in funding. The most recent round on record is Series C.

How many employees does VitriVax have?

VitriVax has approximately 52 people on record.

SEC filings, insider activity, nonprofit links and pay benchmarks for VitriVax:

Company details: from public sources. Funding: no announced round on file. Ownership: not yet claimed by the company. Scores: measured by named tools; each links to its method. Our rules

Categories

Need more than this profile? Deep intel researches any company website: team, funding, customers and tech.

Max Agent

Let Max Agent watch VitriVax and its market for you

New competitors, funding rounds, pricing and product changes, and where you show up in AI answers, in one weekly report.

Free week

Starter listings, once

AI answers checked

Daily for 7 days

  • ChatGPT
  • Perplexity

Max Agent

$79 a month, or $9.99 with our badge on your site

AI answers checked

Every week

  • ChatGPT
  • Claude
  • Perplexity
  • Gemini